首页> 中文期刊> 《中国社区医师》 >急性心肌梗死后继发室性心律失常应用胺碘酮对比利多卡因的临床效果研究

急性心肌梗死后继发室性心律失常应用胺碘酮对比利多卡因的临床效果研究

         

摘要

目的:观察急性心肌梗死后继发室性心律失常应用胺碘酮和利多卡因治疗的临床效果。方法:收治心肌梗死后继发室性心律失常患者80例,随机分为观察组与对照组各40例,观察组采用胺碘酮治疗,对照组采用利多卡因治疗,对比两组的临床疗效。结果:观察组的治疗效果显著,观察组的治疗总有效率明显高于对照组(P<0.05);观察组不良反应总发生率显著低于对照组(P<0.05)。结论:急性心肌梗死后继发室性心律失常患者应用胺碘酮治疗效果显著,且不良反应发生率低。%Objective:To observe the clinical effect of amiodarone and lidocaine treatment in secondary ventricular arrhythmia after acute myocardial infarction.Methods:80 patients with secondary ventricular arrhythmia after acute myocardial infarction were selected.They were randomly divided into the observation group and the control group with 40 cases in each.The observation group was given amiodarone treatment.The control group was given lidocaine treatment.The clinical curative effects of two groups were compared.Results:The treatment effect of the observation group was significant.The treatment total effective rate of the observation group was significantly higher than that of the control group(P<0.05).The total incidence rate of adverse reactions in the observation group was significantly lower than that of the control group(P<0.05).Conclusion:Amiodarone in the treatment of secondary ventricular arrhythmia after acute myocardial infarction has a significant treatment effect,and the incidence rate of adverse reactions is low.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号